Italy vs Kazakhstan: Memorandum items, Financial derivatives (net marked to market)

Italy
357,270
in 2025
Kazakhstan
1.06 million
in 2025
Italy rank
23rd
Kazakhstan rank
22nd

Memorandum items, Financial derivatives (net marked to market) over time

  • Italy
  • Kazakhstan
-100.0M-50.0M050.0M100.0M200020122025

How they compare

Kazakhstan currently reports 1.06 million against 357,270 in Italy, a difference of 703,750.

That makes Kazakhstan's figure about 3.0 times Italy's.

The two have swapped places 6 times across 20 shared years of data; in 2003 it was Kazakhstan ahead.

Italy ranks 23rd and Kazakhstan ranks 22nd of 66 countries.

Kazakhstan has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Italy Kazakhstan Difference Ahead
2000s 0 3.00 million 3.00 million Kazakhstan
2010s -2.16 million 9.55 million 11.71 million Kazakhstan
2020s 2.23 million 17.77 million 15.54 million Kazakhstan

Averages of every year both report within each decade.

Frequently asked questions

Which has higher memorandum items, financial derivatives (net marked to market), Italy or Kazakhstan?
Kazakhstan, at 1.06 million against 357,270 in Italy as of 2025.
What is the difference in memorandum items, financial derivatives (net marked to market) between Italy and Kazakhstan?
703,750, with Kazakhstan ahead.
How many years of comparable data are there for Italy and Kazakhstan?
20 years are reported by both, from 2003 to 2025.
How do Italy and Kazakhstan rank globally for memorandum items, financial derivatives (net marked to market)?
Italy ranks 23rd and Kazakhstan ranks 22nd of 66 countries.
Where does this data come from?
International Monetary Fund, published as Memorandum items, Financial derivatives (net marked to market), Assets (International Reserves and Foreign Currency Liquidity: Guidelines for a Data Template 2013 (IRFCL 2013), Monetary Authorities and Central Government excluding Social Security). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Italy vs Kazakhstan: Memorandum items, Financial derivatives (net marked to market). Statizoid, drawing on International Monetary Fund. Retrieved 15 September 2026, from https://financial-sector.statizoid.com/compare/memorandum-items-financial-derivatives-net-marked-to-market-assets-international-reserves/italy/kazakhstan/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under IMF Terms and Conditions (attribution required); please keep the attribution.

<a href="https://financial-sector.statizoid.com/compare/memorandum-items-financial-derivatives-net-marked-to-market-assets-international-reserves/italy/kazakhstan/">Italy vs Kazakhstan: Memorandum items, Financial derivatives (net marked to market)</a> — Statizoid

About this data

Indicator
Memorandum items, Financial derivatives (net marked to market), Assets (International Reserves and Foreign Currency Liquidity: Guidelines for a Data Template 2013 (IRFCL 2013), Monetary Authorities and Central Government excluding Social Security)
Source
International Monetary Fund
Licence
IMF Terms and Conditions (attribution required)
Coverage
68 places, 1,199 data points, 1999–2025
Last refreshed

The International Reserves and Foreign Currency Liquidity (IRFCL, or the “Reserves Data Template”) dataset includes data on the amount and composition of countries’ official reserve assets, other foreign currency assets held by monetary authorities and central governments, and short-term foreign currency obligations and related activities of monetary authorities and central governments that can lead to drains on official reserves and other foreign currency assets. This website re-disseminates IMF member countries' data on international reserves and foreign currency liquidity in a common template and in a common currency (the U.S. dollar). Historical data by country are also available. Please note that the re-dissemination of the template data by the Fund does not constitute endorsement of the quality of the data by the Fund.